Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.46 |
| ▸ | RELA | Q04206 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 5/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.44 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8607879 | 0.98 | MEN1 (0.48) | MEN1KMT2AMAPTNPC1RAB9A | |
| SCHEMBL8956496 | 0.88 | APP (0.40) | MEN1KMT2AMAPTNPC1RAB9A | |
| SCHEMBL8412982 | 0.87 | NPC1 (0.38) | MEN1KMT2AMAPTNPC1RAB9A | |
| SCHEMBL17328232 | 0.85 | MEN1 (0.37) | MEN1KMT2AMAPTNPC1RAB9A | |
| SCHEMBL125466 | 0.82 | MEN1 (0.44) | MEN1KMT2AMAPTNPC1RAB9A | |
| SCHEMBL125517 | 0.82 | NPC1 (0.50) | MEN1KMT2AMAPTNPC1RAB9A | |
| SCHEMBL125596 | 0.80 | DEGS1 (0.56) | MAPTPOLB | |
| SCHEMBL4147627 | 0.80 | NPC1 (0.40) | MEN1KMT2AMAPTNPC1RAB9A | |
| SCHEMBL10071737 | 0.80 | DEGS1 (0.56) | MAPTPOLB | |
| SCHEMBL14622036 | 0.80 | MEN1 (0.45) | MEN1KMT2AMAPTNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230287179-A1 | HIGHLY SOLUBLE TRIS-(2,3-EPOXYPROPYL)-ISOCYANURATE AND METHOD FOR PRODUCING SAME | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| US-20230287179-A1 | HIGHLY SOLUBLE TRIS-(2,3-EPOXYPROPYL)-ISOCYANURATE AND METHOD FOR PRODUCING SAME | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| WO-2020066851-A1 | ACRYLIC COATING COMPOSITION CONTAINING INORGANIC OXIDE PARTICLES | 日産化学株式会社 | 2020-04-02 | — | — | WO | disclosed |
| US-20190256657-A1 | HIGHLY SOLUBLE TRIS- (2, 3-EPOXYPROPYL)- ISOCYANURATE AND METHOD FOR PRODUCING SAME | NISSAN CHEMICAL CORPORATION (JP) | 2019-08-22 | — | — | US | disclosed |
| US-9428606-B2 | Polyfunctional epoxy compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-08-30 | — | — | US | disclosed |
| US-9428606-B2 | Polyfunctional epoxy compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-08-30 | — | — | US | disclosed |
| US-20150353684-A1 | HIGHLY SOLUBLE TRIS- (2, 3-EPOXYPROPYL)- ISOCYANURATE AND METHOD FOR PRODUCING SAME | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-12-10 | — | — | US | disclosed |
| US-9140989-B2 | Photosensitive organic particles | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-09-22 | — | — | US | disclosed |
| US-9140989-B2 | Photosensitive organic particles | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-09-22 | — | — | US | disclosed |
| US-8828651-B2 | Positive-type photosensitive resin composition and cured film manufactured therefrom | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-09-09 | — | — | US | disclosed |
| US-7341775-B2 | Composition for forming porous film, porous film and method for forming the same, interlevel insulator film, and semiconductor device | MATSUSHITA ELECTRIC INDUSTRIAL CO. LTD. (JP) | 2008-03-11 | — | — | US | disclosed |
| US-7285375-B2 | Photosensitive composition, photosensitive lithography plate and method for producing lithography plate | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-10-23 | — | — | US | disclosed |
| US-7285375-B2 | Photosensitive composition, photosensitive lithography plate and method for producing lithography plate | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-10-23 | — | — | US | disclosed |
| EP-1795553-A1 | PROCESS FOR PRODUCING FOAM | Oji Paper Co., Ltd. (JP) | 2007-06-13 | — | — | EP | disclosed |
| US-20070020559-A1 | Positive-type photosensitive resin composition and cured film manufactured therefrom | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-01-25 | — | — | US | disclosed |
| US-20070020559-A1 | Positive-type photosensitive resin composition and cured film manufactured therefrom | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-01-25 | — | — | US | disclosed |
| US-20070020555-A1 | Photosensitive composition, photosensitive lithography plate and method for producing lithography plate | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-01-25 | — | — | US | disclosed |
| US-20070020555-A1 | Photosensitive composition, photosensitive lithography plate and method for producing lithography plate | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-01-25 | — | — | US | disclosed |
| US-20060210785-A1 | Foamed product in a sheet form and method for production thereof | OJI PAPER CO., LTD. (JP) | 2006-09-21 | — | — | US | disclosed |
| EP-1647570-A1 | FOAMED PRODUCT IN A SHEET FORM AND METHOD FOR PRODUCTION THEREOF | Oji Paper Co., Ltd. (JP) | 2006-04-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230287179-A1 | HIGHLY SOLUBLE TRIS-(2,3-EPOXYPROPYL)-ISOCYANURATE AND METHOD FOR PRODUCING SAME | TTPA, USP1, USP2 | MEN1 4080/4885KMT2A 2014/4885MAPT 70/4885 |
| US-20190256657-A1 | HIGHLY SOLUBLE TRIS- (2, 3-EPOXYPROPYL)- ISOCYANURATE AND METHOD FOR PRODUCING SAME | TTPA, USP1, USP2 | MEN1 4080/4885KMT2A 2014/4885MAPT 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.